{'fraction_non_alphanumeric': 0.02465986394557823, 'fraction_numerical': 0.034013605442176874, 'mean_word_length': 5.649717514124294, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Arachidonic acid activates phospholipase D in human neutrophils; essential role of endogenous leukotriene B4 and inhibition by adenosine A2A receptor engagement

We report in human neutrophils (PMN) that phospholipase D (PLD) was stimulated by micromolar concentrations of arachidonic acid (AA) and nanomolar concentrations of leukotriene B4 (LTB4), and eicosapentaenoic acid was inactive. The stimulatory effect of AA occurred only when adenosine was eliminated from PMN suspensions or when PMN were incubated with adenosine A2A receptor antagonists. The mechanism of AA‐induced PLD activation was investigated. The results show that AA‐ and LTB4‐induced PLD activation were inhibited by the LTB4 receptor 1 (BLTR1) antagonist CP 105,696, whereas the LTA4 hydrolase inhibitor SC57461A and the LT biosynthesis inhibitor MK‐0591 inhibited AA‐ but not LTB4‐mediated PLD activation. The AA‐induced ARF1 and RhoA translocation to PMN membranes was inhibited by CP 105,696 and SC57461A. These results provide evidence of a requirement for an autocrine‐stimulatory loop involving LTB4 and BLTR1 in the translocation of small GTPases to membranes and the activation of PMN PLD by AA.